Details of the Drug

General Information of Drug (ID: DM5BHCW)

Drug Name

RQNestin 34.5

Indication

Disease Entry	ICD 11	Status	REF
Recurrent glioblastoma	2A00.00	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Oncolytic virus

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03152318) A Phase I Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2, a Genetically Engineered HSV-1 Virus, and Immunomodulation With Cyclophosphamide. U.S.National Institutes of Health.